Influence of MPP+ on the state of tubulin polymerisation in NGF- differentiated PC12 cells

Journal of Neuroscience Research

Volumn 56, Issue 1, 1999, Pages 28-35

  Cappelletti, Graziella ^a   Maggioni, M Grazia ^a   Maci, Rosalba ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Cytoskeleton; MPP+; Parkinson's disease; Polymerisation; Synthesis

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; NERVE GROWTH FACTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN; CYTOSKELETON; DOPAMINERGIC NERVE CELL; FEEDBACK SYSTEM; IMMUNOPRECIPITATION; MICROTUBULE ASSEMBLY; NERVE CELL DEGENERATION; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; CELL DIFFERENTIATION; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; KINETICS; MACROMOLECULAR SUBSTANCES; MICROTUBULES; NERVE GROWTH FACTORS; NEUROTOXINS; PC12 CELLS; RATS; TUBULIN;

EID: 0033118430     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19990401)56:1<28::AID-JNR4>3.0.CO;2-2     Document Type: Article

References (48)

1. Anglade P, Vyas S, Javoyagid F, Herrero MT, Michel PP, Marquez J, Mouattprigent A, Ruberg M, Hirsch EC, Agid Y. 1997. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol 12:25-31.
2. Black MM, Aletta JM, Greene LA. 1986. Regulation of microtubule composition and stability during nerve growth factor-promoted neurite outgrowth. J Cell Biol 103:545-557.
3. Bradford M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dyebinding. Anal Biochem 72:245-248.
4. Burns RS, Chiuech CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin I. 1983. A primate model of Parkinsonism: selective destruction of dopaminergic neurones in the pars compacta of the substantia nigra by N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80:4546-4550.
5. Cappelletti G, Camatini M, Brambilla E, Maci R. 1991. N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induces cytoskeletal alterations on "Swiss 3T3" mouse fibroblasts. Neurosci Lett 129:149-152.
6. - neurotoxicity on NGF-differentiated PC12 cells. Cell Biol Int 19:687-693.
7. Cappelletti G, Maggioni MG, Candia Carnevali MD, Bonasoro F, Maci R. 1996. Dynamic changes in the state of actin polymerisation in human alveolar cells exposed to the oxidant agent paraquat. Eur J Cell Biol 71:293-302.
8. Carlier MF, Didry D, Pantaloni D. 1987. Microtubule elongation and guanosine 5′-triphosphate hydrolysis: role of guanine nucleotides in microtubule dynamics. Biochemistry 26:4428-4437.
9. - selectively affects calcium homeostasis in mesencephalic cell cultures from embryonal C57/B16 mice. J Neural Transm-Gen 100:153-163.
10. Cleeter MWJ, Cooper JM, Schapira AHV. 1992. Irreversible inhibition of mitochondrial complex 1 by 1-methyl-4-phenylpyridinium: evidence for free radical involvement. J Neurochem 58:786-789.
11. Cleveland DW. 1989. Autoregulated control of tubulin synthesis in animal cells. Curr Opin Cell Biol 1:10-14.
12. De Girolamo LA, Hargreaves AJ, Billet EE. 1997. Axon outgrowth and neurofilament protein expression in mouse neuroblastoma cells exposed to the neurotoxin MPTP. Biochem Soc Trans 25:S575.
13. Denton T, Howard BD. 1987. Adopaminergic cell line variant resistant to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Neurochem 49:622-630.
14. Desai A, Mitchison TJ. 1997. Microtubule polymerisation dynamics. Annu Rev Cell Dev Biol 13:83-117.
15. Dipasquale B, Marini AM, Youle RJ. 1991. Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons. Biochem Biophys Res Commun 181:1442-1448.
16. Eickson HP, O'Brien ET. 1992. Microtubule dynamic instability and GTP hydrolisis. Am Rev Biophys Biomol Struct 21:145-166.
17. Fahn S, Cohen G. 1992. The oxidative stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 32:804-812.
18. Fornai F, Vaglini F, Maggio R, Bonuccelli U, Corsini GU. 1996. Exicitatory amino acids and MPTP toxicity. Adv Neurol 69:167-176.
19. Forno LS, Sternberger LA, Sternberger NH, Strefling AM, Swanson K, Eng LF. 1986. Reaction of Lewy bodies with antibodies to phosphorylated and non-phosphorylated neurofilaments. Neurosci Lett 64:253-258.
20. Forno LS, Langston JW, DeLanney LE, Irwin I. 1988. An electron microscopic study of MPTP-induced inclusion bodies in an old monkey. Brain Res 448:150-157.
21. Forno LS, DeLanney LE, Irwin I, Langston JW. 1996. Electron microscopy of Lewy bodies in the amygdala-parahippocampal region. Comparision with inclusion bodies in the MPTP-treated squirrel monkey. Adv Neurol 69:217-228.
22. Galloway PP, Grunglke-Iqbal I, Iqbal K, Perry G. 1988. Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles. J Neuropathol Exp Neurol 47:654-663.
23. Galloway PP, Mulvihill P, Perry G. 1992. Filaments of Lewy bodies contain insoluble cytoskeletal elements. Am J Pathol 140:809-822.
24. Goldman JE, Yen S-H, Chiu F-C, Peress NS. 1983. Lewy bodies of Parkinson's disease contain neurofilament antigens. Science 221:1082-1084.
25. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. 1986. Abnormal phosphorylation of the microtubuleassociated protein tau in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 88:4913-4917.
26. Hartley A, Stone JM, Heron C, Cooper JM, Schapira AH. 1994. Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease. J Neurochem 63:1987-1990.
27. Hasegawa E, Takcshige K, Oishi T, Murai Y, Minikami S. 1990. 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation, and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. Biochem Biophys Res Commun 170:1049-1055.
28. Javitch JA, D'Amato RJ, Strittmatter SM, Snyder SH. 1985. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 82:2173-2177.
29. Keith CH, Bajer AS, Ratan R, Maxfield FR, Shelanski ML. 1986. Calcium and calmodulin in the regulation of the microtubular cytoskeleton. Ann NY Acad Sci 466:375-391.
30. Khawaja S, Gundersen GG, Bulinski JC. 1986. Enhanced stability of microtubules enriched in detyrosinated tubulin is not a direct function of detyrosination level. J Cell Biol 106:141-149.
31. Langston JW, Ballard P, Tetrud JW, Irwin I. 1983. Chronic Parkinsonism due to a product of meperidine-analog synthesis. Science 219:979-980.
32. Lee GL. 1993. Non-motor microtubule-associated proteins. Curr Opin Cell Biol 5:88-94.
33. Lee VM-Y, Blain BJ, Otvos LJ Jr, Trojanowski JQ. 1991. A68: A major subunit of paired helical filaments and derivatized forms of normal tau. Science 251:675-678.
34. Manetto V, Perry G, Tabaton M, Mulvihill P, Fried VA, Smith HT, Gambetti P, Autilio-Gambetti L. 1988. Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases. Proc Natl Acad Sci USA 85:4501-4505.
35. + in PC12 pheochromocytoma cells: binding and biological studies. Neurosci Lett 94:349-354.
36. Mochizuki H, Goto K, Moti H, Mizuno Y. 1996. Histochemical detection of apoptosis in Parkinson's disease. J Neurol Sci 137:120-123.
37. Montine TJ, Farris DB, Graham DG. 1995. Covalent crosslinking of neurofilament proteins by oxidised catechols as a potential mechanism of Lewy body formation. J Neuropathol Exp Neurol 54:311-319.
38. Nicklas WJ, Vyas I, Heikkila RE. 1985. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine. a metabolite of the neurotoxin 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci 36:2503-2508.
39. Pedrotti B, Soffientini A, Islam K. 1993. Sulphonate buffers affect the recovery of microtubule-associated proteins MAP1 and MAP2: evidence that MAP1A promotes microtubule assembly. Cell Motil Cytoskeleton 25:234-242.
40. Pollanen MS, Dickson DW, Bergeron C. 1993. Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 52:183-191.
41. Schapira AHV, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD. 1989. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54:823-827.
42. Seaton TA, Cooper JM, Shapira AH. 1997. Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors. Brain Res 777:110-118.
43. Singer TP, Castagnoli N, Ramsay RR, Trevor AJ. 1987. Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Neurochem 49:1-8.
44. Song X, Ehrich M. 1998. Alterations of cytoskeletal tau proteins of SH-SY5Y human neuroblastoma cells after exposure to MPTP. Neurotoxicology 19:73-82.
45. Song X, Perkins S, Jortner BJ, Ehrich M. 1997. Cytotoxic effects of MPTP on SH-SY5Y human neuroblastoma cells. Neurotoxicology 18:341-354.
46. Tompkins MM, Basgall EJ, Zamrini E, Hill WD. 1997. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. Am J Pathol 150:119-131.
47. - neurotoxicity by N-methyl-D-aspartate antagonists. Nature 349:414-418.
48. Zhang J, Pieper A, Snyder SH. 1995. Poly(ADP-ribose) synthetase activation: an early indicator of neurotoxic DNA damage. J Neurochem 65:1411-1414.